Yale Expert Delivers Talk at White House on Role of Addiction Specialists in Hospitals
On June 25, Yale School of Medicine’s Dr. Jeanette Tetrault spoke at a convening of the President’s Opioid Commission and the Office of National Drug Control Policy. The purpose of the meeting was to discuss the steps needed to build a national addiction medicine workforce and give Americans access to the care they need. Her talk, which focused on the role of addiction medicine specialists in emergency departments (EDs), was part of a congressional briefing sponsored by the American College of Academic Addiction Medicine.
Implementation Science: Putting Important Discoveries to Their Best Use
Scientific innovations are created every day, but how do we ensure that they are used efficiently and reach the people who need them most? David Chambers, DPhil, deputy director for implementation science in the Division of Cancer Control & Population Sciences at the National Cancer Institute, tackled that question during his June 25 grand rounds lecture titled “Advancing the Science of Implementation in Cancer Control: An NCI Perspective."
New England Journal of Medicine article by Yale researchers highlights efforts to combat opioid crisis in ED 24/7/365
Yale researchers, Gail D’Onofrio, M.S., M.D, and Kathryn Hawk, M.D, M.P.H., along with Ryan McCormack, M.D., Assistant Professor at the Ronald O. Perelman Department of Emergency Medicine, recently published a groundbreaking article in The New England Journal of Medicine focusing on the importance of engaging patients with OUD in opioid-agonist treatment.
Project ASSERT celebrates 20 years of providing lifesaving substance use services
This year marks the 20th anniversary of Project ASSERT (Alcohol & Substance use Services, Education, & Referral to Treatment), which provides lifesaving services to Yale New Haven Hospital Emergency Department patients with substance-use disorders.
Yale doctor helps highlight for worldwide focus on ‘silent killers’
In today’s world, non-communicable diseases (NCDs) such as cancers, heart and respiratory disease, diabetes, and Alzheimer’s — to name just a few — have quietly emerged as a pandemic of silent killers to collectively become the leading cause of death worldwide. Overall according to the World Health Organization (WHO), NCDs are responsible for more than 38 million deaths a year — more than all other causes combined.
VOICES Project to Curb Elder Abuse Is Kicked off at Yale Event with Senator Blumenthal
The Department of Emergency Medicine (DEM) at Yale School of Medicine kicked off the start of a new project to combat elder mistreatment (EM) with a community event at Monterey Place in New Haven, Connecticut on Friday, Jan. 4.
Nora D. Volkow, MD, Director of the National Institute on Drug Abuse meets with Yale-DAHRS Scholars
On Friday, October 5, Scholars representing the Yale-Drug use, Addiction and HIV Research Scholars (DAHRS) program were fortunate to have the opportunity to meet with Nora D. Volkow, MD, Director of the National Institute on Drug Abuse.
New Centers to Advance Implementation and Prevention Sciences
Two new centers at the School of Medicine and the School of Public Health will promote the adoption of research findings into clinical practice and develop and assess sustainable, cost-effective interventions to improve public health domestically and around the world.
D'Onofrio highlights heroes fighting opioid epidemic in Emergency Medicine conference keynote
In May, D’Onofrio and her department were honored at the annual meeting of the Society for Academic Emergency Medicine (SAEM), the field’s research arm. D’Onofrio was selected to give the keynote address, and Yale residents and faculty members received awards and accolades.
Dr. Barbara Banz Wins Award at 1st Annual Yale University Post-Doc Research Symposium
Barbara Banz, PhD, the Department of Emergency Medicine’s (DEM) DrivSim Lab Post-Doctoral Associate, was awarded “Outstanding Oral Presentation” for her presentation at the First Annual Yale University Postdoc Symposium held on Friday, June 8th.
For Many Strokes, There’s an Effective Treatment. Why Aren’t Some Doctors Offering It?
Dr. Christopher Lewandowski, principal investigator of a clinical trial that found an effective treatment for stroke. Two decades later, he still finds himself explaining the data to doubters in the medical community.